View drug registration information details.


ItemsRegistration information
ID657
No657
Brand NameXANILO 30 MG DDR CAPSULE
IngredientsDEXLANSOPRAZOLE DUAL DELAYED RELEASE PELLETS EQ.TO DEXLANSOPRAZOLE 30 MG
Dosage FormCAPSULE
Primary PackagingALU-ALU BLISTER
StorageSTORE BELOW 30 C
Shelf Life24 MONTHS
Pack SizeBOX OF 3 X 10'S
Dispensing CategoryPrescription only
ATC Classification
Pharmaceutical ClassDRUG RELATED TO ACID DISOEDER
Indications• Healing of Erosive Esophagitis Xanilo is indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis (EE) for up to eight weeks. •Maintenance of Healed Erosive Esophagitis and Relief of Heartburn Xanilo is indicated in patients 12 years of age and older to maintain healing of EE and relief of heartburn for up to six months in adults and 16 weeks in patients 12 to 17 years of age. • Treatment of Symptomatic Non-Erosive Gastroesophageal Reflux Disease Xanilois indicated in patients 12 years of age and older for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD) for four weeks.
Contraindications
Side Effects
Unit Price
EDL No
DescriptionHard HPMC capsule size #3, light blue opaque cap and iron grey opaque body, containing off white to light brownish colored, dual delayed released spherical pellets
NoteONLINE
License OwnerEXAMED CO.,LTD
ManufacturerMARTIN DOW LTD
CountryPAKISTAN
Import Registration No108828
Import Registration Date2021-07-30
ActivityCERTIFICATE RELEASED
Applied Date2024-07-19
FDD Registration No01 I 5857/25
FDD Registration Date2025-01-23
Expiry Date2030-01-22

Back to drug list